Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2008-05-20
2008-05-20
Foley, Shanon (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C424S050000, C424S094100, C424S093460, C435S071200, C530S350000
Reexamination Certificate
active
07374874
ABSTRACT:
The invention provides bacteriophages that infectBacillusbacteria, includingBacillus anthracis, and compositions containing the bacteriophages. The invention also provides methods for using the bacteriophages of the invention to prevent and treat infection of an organism byBacillusbacteria. Methods and materials to decontaminate a surface or an organism that is contaminated withBacillusbacteria orBacillusspores is also provided.
REFERENCES:
patent: 5660812 (1997-08-01), Merril et al.
patent: 5679510 (1997-10-01), Ray et al.
patent: 5688501 (1997-11-01), Merril et al.
patent: 5766892 (1998-06-01), Merril et al.
patent: 5811093 (1998-09-01), Merril et al.
patent: 6030610 (2000-02-01), Handelsman et al.
patent: 6033659 (2000-03-01), Handelsman et al.
patent: 2004/0063189 (2004-04-01), Walter
patent: WO-2006083288 (2006-08-01), None
Attwood, T. K. ,Science vol. 290, Oct. 20, 2000.
Biswas et al. Infection and Immunity Vo. 70, No. 1, pp. 204-210, Jan. 2002.
Groisman et al. ,Proc. Natl. Acad. Sci., vol. 81, pp. 1480-1483, Mar. 1984.
Walter, M. H., et al., “Destroying bacterial bio-warfare agents: growth, stability and genetic characterization of bacteriophage CP-51, lytic onBacillus anthracisandB. cereus”,Abstracts of the General Meeting of the American Society for Microbiology, 100, (May 2000),448.
Walter, M. H., “Efficacy and durability ofBacillus anthracisbacteriophages used against spores”,Journal of Environmental Health, 66 (1), (Jul. 2003).
Walter, M. H., et al., “ThreeBacillus anthracisbacteriophages from topsoil”,Current Microbiology,47 (1), (Jul. 2003),55-58.
Weber-Dabrowska, B. , et al., “Effective phage therapy is associated with normalization of cytokine production by blood cell cultures.”,Arch Immunol Ther Exp(Warsz), 48(1), (2000),31-37.
Yelton, D. B., et al., “Comparison ofBacillus cereusbacteriophages CP-51 and CP-53”,J Virol., 8(2), (Aug. 1971),242-253.
Yelton, D. B., et al., “Transduction inBacillus cereusby each of two bacteriophages”,J Bacteriol., 102(2):, (May 1970),573-579.
Helgason, Erlendur , et al., “Bacillus anthracis, Bacilus cereus, andBacillus thuringiensis—one species on the basis of genetic evidence”,Applied and Environmental Microbiology, (Jun. 2000),2627-2630.
Hughes, Jennifer B., et al., “Counting the uncountable: statistical approaches to estimating microbial diversity”,Applied and Environmental Microbiology, (Oct. 2001),4399-4406.
Kortepeter, Mark G., et al., “Potential biological weapons threats”,Emerging Infectious Diseases, 5(4), (1999).
Kudva, I. T., et al., “Biocontrol ofEscherichia coliO157 with O157-specific bacteriophages”,Appl Environ Microbiol., 65(9), (Sep. 1999),3767-3773.
Kutter, Elizabeth , “Phage therapy: bacteriophages as antibiotics: addendum”, http://www.evergreen.edu/phage/polishresearch/addendu2000.htm, (2000),15 pages.
Lederberg, J , “Smaller fleas . . . ad infinitum: therapeutic bacteriophage redux”,Proc Natl Acad Sci U S A., 93(8), (Apr. 16, 1996),3167-3168.
Leverentz, B. , et al., “Examination of bacteriophage as a biocontrol method forSalmonellaon fresh-cut fruit: a model study”,J Food Prot 64(8), (Aug. 2001),1116-1121.
Levin, Bruce R., et al., “Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics”,The American Naturalist, 147(6), (Jun. 1996),881-898.
Merril, C. R., “Bacteriophage interactions with higher organisms”,Trans N Y Acad Sci., 36(3), (Mar. 1974),265-272.
Merril, C. R., et al., “Long-circulating bacteriophage as antibacterial agents”,Proc Natl Acad Sci U S A., 93(8), (Apr. 16, 1996),3188-3192.
Schuch, R. , et al., “A bacteriolytic agent that detects and killsBacillus anthracis”, Nature, 418 (6900), (Aug. 22, 2002).
Sulakvelidze, Alexander , et al., “Bacteriophage therapy”,Antimicrob Agents Chemother 45(3), (Mar. 2001),649-659.
Thorne, C. B., et al., “Cold lability ofBacillus cereusbacteriophage CP-51”,J Virol., 14(4), (Oct. 1974),1008-1012.
Thorne, C. B., “Transduction inBacillus cereusandBacillus anthracis”, Bacteriol Rev., 32(4 Pt 1), (Dec. 1968),358-361.
Twort, F. W., et al., “An investigation on the nature of ultra-microscopic viruses”,Lancet, vol. II, (Dec. 4, 1915),1241-1243.
Van Regenmortel, et al., “Virus taxonomy”,7th report of the International Committee on Taxonomy of Viruses, Academic Press, San Diego, (2000),43-52.
Van Tassel, R. L., et al., “Response ofBacillus thuringiensisto bacteriophage CP-51”,Can J Microbiol., 22(4), (Apr. 1976),583-586.
Ackermann, et al., “Family podoviridae”,virus taxonomy : classification and nomenclature of viruses : seventh report of the International Committee on Taxonomy of Viruses, SanDiego : Academic Press,(2000),106-109.
Alavidze, Z. , et al., “Isolation and characterization of lytic phages against selectedSalmonellaserotypes”,ASM 100th General Meeting, Los Angeles, CA, (2000).
Alisky, J. , et al., “Bacteriophages show promise as antimicrobial agents”,J Infect., 36(1), (Jan. 1998),5-15.
Barrow, P. A., et al., “Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential”,Trends Microbiol., 5(7), (Jul. 1997),268-271.
Barrow, P. , et al., “Use of lytic bacteriophage for control of experimentalEscherichia colisepticemia and meningitis in chickens and calves”,Clin Diagn Lab Immunol., 5(3), (May 1998),294-8.
Cowles, P. B., et al., “Effect of bacteriophage on experimental anthrax in white mice”,Journal of Infectious Diseases, 49, (1931),264-269.
Eiserling, F. A., et al., “Capsomeres and other structures observed on some bacteriophases”,Pathologia et microbiologia(Basel), 28, (1965),175-180.
Fitzgerald, Deborah A., “Making every nanoliter count”,The Scientist, (Oct. 29, 2001),22-23, 26.
Fox, Jeffrey L., “Phage treatments yield healthier tomato, pepper plants”,ASM News 66(8), (2000),455-456.
Akimkin, V. G., et al., “Practical use of adaptedSalmonellabacteriophage for the treatment and prevention of nosocomial infections”,Zh Mikrobiol Epidemiol Immunobiol.,(6), Article in Russian—English translation and Certification of English Translation attached (Nov.-Dec. 1998),85-6.
D'Herelle, M. F., et al., “MICROBIOLOGY—On an invisible antagonist microbe of the dysentery bacteria” Microbiologie—Sur un microbe invisible antagoniste des bacilles dysenteriques). Note of M.F. D'Herelle, presented by M. Roux,C R Acad Ser D, 165, Article in French—English translation and Certification of English Translation attached; (Jul.-Dec. 1917),373-375.
Regenmortel, et al., “Virus taxonomy, 7th report of the International Committee on Taxonomy of Viruses” (2000).
Sneath, Peter H., “Endospore-forming gram-positive rods and cocci”,Holt, Bergey's Manual of Systematic Bacteriology, Section 13, Baltimore, Williams&Wilkins, (1984),1104-1121.
Foley Shanon
Fredrikson & Byron , P.A.
Shahnan-Shah Khatol S.
University of Northern Iowa Research Foundation
LandOfFree
Bacteriophages that infect Bacillus bacteria (Anthrax) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacteriophages that infect Bacillus bacteria (Anthrax), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacteriophages that infect Bacillus bacteria (Anthrax) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2786098